Owens Julia C. 4
4 · Millendo Therapeutics, Inc. · Filed Mar 19, 2021
Insider Transaction Report
Form 4
Owens Julia C.
DirectorPresident and CEO
Transactions
- Award
Stock Option (right to buy)
2021-03-17+24,000→ 24,000 totalExercise: $2.29Exp: 2031-03-16→ Common Stock (24,000 underlying)
Footnotes (1)
- [F1]One-third (1/3) of the shares subject to this option shall vest on February 1, 2022, and one twenty-fourth (1/24th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. However, all such options, to the extent outstanding immediately prior to a Change in Control (as defined in the 2019 Equity Incentive Plan), will be (or will be deemed to have been) fully vested and exercisable as of immediately prior to such Change in Control.